YOLFTbeta
XI

Numeral Limited

XII · JSE · Healthcare / Drug Manufacturers - Specialty & Generic

25.00ZAC+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close25.00
Open25.00
Day Range25.00 – 25.00
52-Week Range0.01 – 35.00
Volume0
Market Cap347.90M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.01
50-Day Avg25.30
200-Day Avg13.44

About

Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. In addition, it offers stem-cell harvesting, storage, and related healthcare and biotechnology activities; and asset management, investment-related activities, and strategic financial initiatives. The company was formerly known as Go Life International Limited and changed its name to Numeral Limited in December 2023. Numeral Limited was incorporated in 2010 and is based in Phoenix, Mauritius.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Patrick David Wysoczanski
  • HeadquartersSayed Hossen Road, Phoenix, Mauritius, South Africa
  • Websitehttps://numeral.co.za

Leadership

  • Mr. Mohamed Yusuf SooklallIndependent Non-Executive Chairman · b. 1960
  • Mr. Marthinus Johannes WolmaransChief Financial Officer · b. 1969
  • Mr. Gerhad Christiaan Jacobus NaudéGroup Advisor · b. 1966
  • Mr. Patrick David WysoczanskiChief Executive Officer
  • Mr. David Van NiekerkExecutive Director · b. 1974
  • Mr. Neville David GrahamExecutive Director
  • Mr. Jacobus Daniel BotmaExecutive Director
  • Mr. J. J. RabieCompany Secretary

Financials

Income Statement

Currency: USD2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-02-282019-02-282020-02-292021-02-282022-02-282023-02-282024-02-292025-02-282026-02-28
Total Revenue-----1.20K1.82M4.14K--10.78083.00K1.69M2.20M
Growth (%)------+151105.32%-99.77%----100.00%-+1939.22%+29.98%
Cost of Revenue----25.2532.67--17.9122.478.78-0368.47K475.73K
Gross Profit-----25.251.17K1.82M4.13K-17.91-22.472-83.00K1.32M1.72M
Gross Margin-----97.34%100.00%99.95%--18.55%-100.00%78.23%78.38%
Operating Expense----119.75925.451.31M2.84K388.09237.5362.84K-61.38K852.12K1.01M
Operating Income335.92K-383.72K-26.23-54.45-145245.55507.43K1.29K-406-260-62.84K-10521.61K471.97K712.87K
Operating Margin-----20.41%27.90%31.29%---582940.63%-26.04%27.88%32.40%
EBITDA335.92K-53.28K-4.23K-3.52K-49.38K252.49997.93K-71.19K-379-261.00K-62.84K14.3621.43K854.28K1.01M
EBITDA Margin-----20.99%54.86%-1721.25%---582940.63%-25.82%50.47%46.06%
Net Income335.92K-383.72K-4.26M-3.57M122.29K18.9575.45K-70.72K-70.11M-261.00K-62.84K-91.2221.61K1.22M79.94K
Net Income Margin-----1.57%31.64%-1709.74%---582940.63%-26.04%71.94%3.63%
Interest Expense-----243.21313.10K548.39-----289.11K667.44K
Interest Expense % of Total Revenue-----20.22%17.21%13.26%-----17.08%30.34%

Balance Sheet

Currency: USD2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-02-282019-02-282020-02-292021-02-282022-02-282023-02-282024-02-292025-02-282026-02-28
Total Assets10.04M9.76M5.22M1.49M1.43M37.16M38.25M34.85M30330330330332.30K2.79M5.48M
Total Liabilities35.19K146.42K172.20K226.46K40.28K3.22K3.77M182.12K588.76K849.58K329.56K420.78K179.27K4.78M5.28M
Total Equity10.00M9.61M5.05M1.26M1.39M33.94M34.48M34.67M-588.46K-849.28K-329.25K-420.48K-146.96K-956.35K745.84K
Cash25.00K3181.22K1.00K1.93K382.8572.72K303303303303303303212.66K266.58K
Total Debt------3.42M---249.69K339.14K103.66K3.97M4.15M
Net Debt-25.00K-318-1.22K-1.00K-1.93K-3822.85M-303-303-303249.38K338.84K103.35K3.76M3.89M

Cash Flow

Currency: USD2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-02-282019-02-282020-02-292021-02-282022-02-282023-02-282024-02-292025-02-282026-02-28
Operating Cash Flow-88.42K-24.68K902-220928-5.45K187.62K-444.31K-34.85M260.8262.84-89.45K-16.41K-2.08M121.43K
Investing Cash Flow-9.55M----2.27K2.30K-128.06K------515.97K-751.72K
Financing Cash Flow9.66M----------89.45K16.41K2.81M675.90K
Capital Expenditure0000000128.06K00000515.97K239.56K
Free Cash Flow-88.42K-24.68K902-220928-5.45K187.62K-572.38K-34.85M260.8262.84-89.45K-16.41K-2.59M-118.13K
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%128.82%100.00%100.00%100.00%100.00%100.00%124.85%-97.28%

Key Statistics & Ratios

Market Cap347.90M
Enterprise Value1.27B
Trailing P/E0.00
Forward P/E0.00
Price / Sales158.46
Price / Book31.26
EPS0.00
Book Value-1.20
Revenue (TTM)2.20M
Gross Profit (TTM)1.70M
EBITDA829.55K
Profit Margin2.07%
Operating Margin26.08%
Return on Equity0.00%
Return on Assets10.56%
Shares Outstanding1.24B
Shares Float2.60M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 28, 20261:10